Rizzo, F
Abaei, A
Nespoli, E
Fegert, J M
Hengerer, B http://orcid.org/0000-0002-7811-9795
Rasche, V
Boeckers, T M
Article History
Received: 20 January 2017
Revised: 20 May 2017
Accepted: 30 May 2017
First Online: 1 August 2017
Competing interests
: During the last 5 years Professor JMF received research funding from the EU, DFG (German Research Foundation), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), German armed forces, several state ministries of social affairs, State Foundation Baden-Württemberg, Volkswagen Foundation, European Academy, Pontifical Gregorian University, RAZ, CJD, Caritas, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from DFG, AACAP, NIMH/NIH, EU, Pro Helvetia, Shire, several universities, professional associations, political foundations, and German federal and state ministries. Clinical trials for Lundbeck, BMBF, Servier. Professor Fegert holds no stocks of pharmaceutical companies. The remaining authors declare no conflict of interest.